Amput, P., Palee, S., Arunsak, B., Pratchayasakul, W., Kerdphoo, S., Jaiwongkam, T., . . . Chattipakorn, N. (2020). PCSK9 inhibitor effectively attenuates cardiometabolic impairment in obese-insulin resistant rats.
استشهاد بنمط شيكاغوAmput, Patchareeya, Siripong Palee, Busarin Arunsak, Wasana Pratchayasakul, Sasiwan Kerdphoo, Thidarat Jaiwongkam, Siriporn C. Chattipakorn, و Nipon Chattipakorn. PCSK9 Inhibitor Effectively Attenuates Cardiometabolic Impairment in Obese-insulin Resistant Rats. 2020.
MLA استشهادAmput, Patchareeya, et al. PCSK9 Inhibitor Effectively Attenuates Cardiometabolic Impairment in Obese-insulin Resistant Rats. 2020.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.